Introducing the new AltIndexLearn more
-$130,000
Net insider buying / selling at Conagra Brands (CAG) over the last 2 years. Updated Jul 21, 2026

Are Conagra Brands Insiders Buying or Selling?

Conagra Brands (CAG) has had 1 insider transaction in the past 90 days, all buys — insider buying is generally read as a bullish signal. The most recent was John Brase, who bought 35,000 shares at $14.59 on July 17, 2026.

Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the CAG AI Score. For government officials trading this stock, see CAG congressional trading.

Recent Conagra Brands Insider Transactions

Insider Transaction Date Type Shares Price Value
John BraseJul 17, 2026Buy35,000$14.59$510,000
John MulliganApr 14, 2026Buy17,500$14.31$250,000
RICHARD LENNYApr 14, 2026Buy25,000$14.34$360,000
Melissa NapierNov 4, 2025Sell13,011$17.19$220,000
THOMAS BROWNOct 7, 2025Buy10,000$18.72$190,000
Thomas McGoughAug 13, 2024Sell40,000$30.29$1.2M

Frequently Asked Questions: Conagra Brands Insider Trading

In the past 90 days, Conagra Brands insiders have made 1 buy and 0 sells. The net buying may indicate insider confidence in the company’s outlook.

The most recent sale was by Melissa Napier who sold 13,011 shares on November 4, 2025. View all transactions in the table on this page.

Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.

Brase John P has bought the most CAG stock in the last 2 years, with a total value of $510,000.

McGough Thomas M has sold the most CAG stock in the last 2 years, with a total value of $1.2M.

The total value of insider transactions for Conagra Brands in the last 2 years is negative, amounting to -$130,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.